Komori
Advanced Media (3773) · FactIncrease in R&D Expenses

Research and development activities in the speech business

First written in FY2017-Q1. 1 of 35 entries say "Restated". Latest entry: FY2026.

35entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY20262016: 220162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 320232024: 320242025: 220252026: 12026
Same theme, other companies
Research and development in cutting-edge devices, AI, and multilingual supportA theme 21 companies write about · 0 as a headwind · 21 as a tailwind

The whole theme swung hardest in 2023: 2 of 18 companies on the "Worse" side.

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.
Full recordFilings, disclosures and news, newest first
  1. FY2026Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥681 million.」

    Annual research and development expenses increased from ¥480 million in the previous fiscal year to ¥681 million. The company advanced research and development on data centers, GPU servers, End-to-End speech recognition, LLMs and multi-stage AI reasoning, among other areas.
  2. FY2026-H1Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥315 million.」

    Research and development expenses for the interim period amounted to ¥315 million, up from ¥206 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  3. FY2025Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥480 million.」

    Annual research and development expenses amounted to ¥480 million, up from ¥453 million in the previous fiscal year. The company advanced research and development on End-to-End speech recognition, LLMs, generative AI, summarization and product function enhancement, among other areas.
  4. FY2025-H1Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥206 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses amounted to ¥206 million, down from ¥236 million in the same period of the previous year.
  5. FY2024Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥453 million.」

    Annual research and development expenses amounted to ¥453 million, up from ¥416 million in the previous fiscal year. The company advanced research and development on End-to-End systems, Transformers, generative AI, conversation and summarization, among other areas.
  6. FY2024-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥346 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Cumulative research and development expenses amounted to ¥346 million, up from ¥308 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  7. FY2024-Q2Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥236 million.」

    Cumulative research and development expenses amounted to ¥236 million, up from ¥200 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  8. FY2024-Q1Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥117 million.」

    The amount spent on research and development activities amounted to ¥117 million, up from ¥89 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  9. FY2023-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥308 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Cumulative research and development expenses amounted to ¥308 million, up from ¥264 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  10. FY2023-Q2Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥200 million.」

    Cumulative research and development expenses amounted to ¥200 million, up from ¥176 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  11. FY2023-Q1Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥98 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses increased from ¥89 million in the same period of the previous year to ¥98 million.
  12. FY2022Decline in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥357 million.」

    Annual research and development expenses amounted to ¥357 million, down from ¥376 million in the previous fiscal year. Meanwhile, the company continued research and development on End-to-End, Bi-LSTM and natural language processing, among other areas.
  13. FY2022-Q3Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥264 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥264 million, down from ¥283 million in the same period of the previous year.
  14. FY2022-Q2Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥176 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥176 million, down from ¥187 million in the same period of the previous year.
  15. FY2022-Q1RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥89 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    The disclosure states that research and development expenses were ¥89 million, unchanged from the same period of the previous year, and that there were no material changes in the status of the activities.
  16. FY2021Decline in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥376 million.」

    Annual research and development expenses amounted to ¥376 million, down from ¥390 million in the previous fiscal year. Meanwhile, the company continued research and development on Bi-LSTM, multilingual recognition, natural language processing and product function enhancement, among other areas.
  17. FY2021-Q3Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥283 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Cumulative research and development expenses amounted to ¥283 million, down from ¥296 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  18. FY2021-Q2Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥187 million.」

    Cumulative research and development expenses amounted to ¥187 million, down from ¥197 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  19. FY2021-Q1Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥89 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses decreased from ¥96 million in the same period of the previous year to ¥89 million.
  20. FY2020Decline in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥390 million.」

    Research and development expenses amounted to ¥390 million, down from ¥402 million in the previous fiscal year. Meanwhile, the company continued development of Bi-LSTM, multilingual recognition, natural language processing and product functions, among other areas.
  21. FY2020-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥296 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Cumulative research and development expenses amounted to ¥296 million, up from ¥284 million in the same period of the previous year. The company stated that there were no material changes in the status of its research and development activities.
  22. FY2020-Q2Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥197 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥197 million, a slight decrease from ¥198 million in the same period of the previous year.
  23. FY2020-Q1Decline in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥96 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses decreased from ¥101 million in the same period of the previous year to ¥96 million.
  24. FY2019Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥402 million.」

    Annual research and development expenses amounted to ¥402 million, up from ¥394 million in the previous fiscal year. The company advanced the development and enhancement of functions for RNN, multilingual recognition and emotion analysis, as well as conversational AI.
  25. FY2019-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥284 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥284 million.
  26. FY2019-Q2Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥198 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥198 million, up from ¥169 million in the same period of the previous year.
  27. FY2019-Q1Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥101 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥101 million, up from ¥82 million in the same period of the previous year.
  28. FY2018Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥394 million.」

    Annual research and development expenses amounted to ¥394 million, up from ¥378 million in the previous fiscal year.
  29. FY2018-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥284 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥284 million.
  30. FY2018-Q2Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥169 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥169 million, up from ¥167 million in the same period of the previous year.
  31. FY2018-Q1Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥82 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses increased from ¥77 million in the same quarter of the previous year to ¥82 million.
  32. FY2017Increase in R&D ExpensesAnnual report

    「As a result, research and development expenses included in selling, general and administrative expenses for the consolidated fiscal year amounted to ¥378 million.」

    Annual research and development expenses amounted to ¥378 million, up from approximately ¥294 million in the previous fiscal year.
  33. FY2017-Q3Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the third quarter of the cumulative consolidated period was ¥274 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, cumulative research and development expenses amounted to ¥274 million.
  34. FY2017-Q2Increase in R&D ExpensesAnnual report

    「The amount spent on research and development activities by the Group as a whole during the second quarter of the cumulative consolidated period was ¥167 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the cumulative consolidated period.」

    Although it stated that there were no material changes in the status of its research and development activities, research and development expenses amounted to ¥167 million.
  35. FY2017-Q1First statedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the first quarter of the cumulative consolidated period was ¥77 million.」

    The company disclosed ¥77 million in research and development expenses for the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Advanced Media yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and development activities in the speech business | Advanced Media,Inc. (3773) | Komori